Asia · Regional markets · Korea Economic Daily
Alteogen clears US patent hurdle as Merck wins all 14 challenges vs Halozyme

Detailed summary
South Korea's Alteogen Inc. has cleared a major US patent hurdle after its partner Merck & Co. prevailed in all 14 challenges against rival Halozyme Therap ...
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.kedglobal.com)



